Emerald Health Therapeutics Inc.
company.status.inactiveCIK 1768225fmd_0X7SZNT7P6NZYNMK21B36B8GBCManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2017 to Dec 31, 2019, 9 periods
| Line item | FY2017 | FY2018 | FY2019 |
|---|---|---|---|
| Total revenues | 1 | 2 | 22 |
| Cost of revenue | 1 | 4 | 21 |
| Gross profit | (0) | (3) | (14) |
| Research and development | 0 | 1 | 4 |
| Selling, general and administrative | 5 | 25 | 19 |
| Operating income | (9) | (37) | (51) |
| Interest expense | – | 0 | 10 |
| Income before taxes | 9 | 31 | 113 |
| Income tax expense | 0 | (0) | (1) |
| Net income from continuing operations | 9 | 31 | 114 |
| Net income | 9 | 31 | 111 |